A clinically validated HealthTech product. A strong founding team. A proof-of-concept that hospital IT directors loved in demos.
And a pipeline of zero.
That was the situation when a B2B HealthTech startup came to Crown in early 2024. Twelve months of outreach had produced two pilots, both stalled. The founders had tried a marketing agency, a freelance SDR, and a part-time marketing hire. Nothing moved the needle.
The problem was not the product. The problem was product marketing.
The Starting State: Strong Product, Wrong Story
The startup had built an AI-powered clinical decision support tool. In clinical terms, the product was excellent. The founders talked about it in clinical terms: efficacy rates, integration depth, compliance certifications.
Their target buyers, hospital IT directors and C-suite administrators, do not make decisions in clinical terms. They make decisions in operational terms: reduced liability, smoother workflow, defensible ROI in a board meeting.
Crown ran a full buyer interview process across 12 decision-makers in target hospitals. The finding was stark: the product’s actual value, from the buyer’s perspective, was not “better clinical decisions.” It was “fewer escalations and one less vendor to manage.” That is a completely different message.
What Crown Did
Phase 1: Repositioning (Weeks 1-4)
Crown rebuilt the messaging architecture from the buyer’s decision map, not from the product’s feature set. The new positioning framed the product as a workflow integration partner, not a clinical intelligence tool. Every asset, from the one-pager to the cold email sequence, was rebuilt around three buyer fears: integration complexity, staff adoption, and compliance risk.
This is the core of product marketing for B2B startups: the product does not change, the story does.
Phase 2: ICP and Account Selection (Weeks 3-6)
The original target list was 400 hospitals, unfocused. Crown ran an ICP workshop and built a tiered account list of 150 hospitals, filtered by system size, recent IT budget signals, and competitive displacement opportunity. The top 50 became the ABM targets.
Phase 3: ABM Campaign (Weeks 5-16)
Crown’s outbound team ran a three-touch ABM sequence: LinkedIn executive outreach, a personalized email sequence referencing each hospital’s recent IT initiatives (sourced via public procurement data), and a short-form case study video. No mass blasts. Every message was written for the named account.
The campaign ran under Crown’s Fractional CMO oversight, with weekly pipeline reviews and message iteration based on response patterns.
The Numbers
Five months after the repositioning:
- 30 hospital pilots secured (baseline: 2 in 12 months)
- 3 LOIs signed, total pipeline value $2.4M ARR
- Average sales cycle reduced from 9 months to 4 months
- Outbound response rate: 12% (industry benchmark: 2-3%)
What Made the Difference
The founders had previously treated marketing and product as separate functions. Crown runs them from the same table.
The Fractional CMO who owned the positioning strategy was the same person who briefed the outbound team. The same team that built the messaging also built the sales enablement. There were no handoffs between a strategy deck and an execution team.
That is not how agencies work. That is how Crown works.
For B2B HealthTech, the path to 30 pilots was not more outbound. It was the right story, in the right language, in front of the right 150 people.
Frequently Asked Questions
What is product marketing for B2B startups?
Product marketing for B2B startups is the function that translates a product’s capabilities into buyer-relevant language. It includes positioning, messaging, ICP definition, and sales enablement. For early-stage startups, it is typically the highest-leverage marketing investment before any paid acquisition.
How long does repositioning take?
Crown runs a full repositioning process in 4-6 weeks: buyer interviews, messaging architecture, and asset rebuild. The market response is visible within the first outbound cycle, typically 2-3 weeks after launch.
Can product marketing work without a large marketing team?
Yes. Product marketing is a function, not a headcount. Crown delivers it as part of a Fractional CMO engagement, which means one contract covering strategy, positioning, and execution. The HealthTech startup in this case study had no full-time marketing staff during the campaign.
What industries does Crown work with?
Crown has run GTM campaigns across SaaS, MedTech, HealthTech, FinTech, ConsumerTech, and ClimTech. The methodology is consistent: buyer map, ICP focus, message architecture, execution.
Ready to build your pipeline? See how Crown has done this for other founders or talk to us directly.
